ID: ALA3393623

Max Phase: Preclinical

Molecular Formula: C24H14Cl6N2O4

Molecular Weight: 607.10

Molecule Type: Small molecule

Representations

Canonical SMILES:  Cc1cc(O)c(C(=O)c2[nH]c(Cl)c(Cl)c2-n2c(C(=O)c3cc(Cl)c(C)cc3O)cc(Cl)c2Cl)cc1Cl

Standard InChI:  InChI=1S/C24H14Cl6N2O4/c1-8-3-16(33)10(5-12(8)25)21(35)15-7-14(27)24(30)32(15)20-18(28)23(29)31-19(20)22(36)11-6-13(26)9(2)4-17(11)34/h3-7,31,33-34H,1-2H3

Standard InChI Key:  DXQMKKKMSDQUKC-UHFFFAOYSA-N

Molecule Features

Natural Product: No

Oral: No

Chemical Probe: No

Parenteral: No

Molecule Type: Small molecule

Topical: No

First In Class: No

Black Box: No

Chirality: No

Availability: No

Prodrug: No

Properties

Molecular Weight: 607.10

Molecular Weight (Monoisotopic): 603.9085

AlogP: 8.22

#Rotatable Bonds: 5

Polar Surface Area: 95.32

Molecular Species: ACID

HBA: 5

HBD: 3

#RO5 Violations: 2

HBA (Lipinski): 6

HBD (Lipinski): 3

#RO5 Violations (Lipinski): 2

CX Acidic pKa: 6.34

CX Basic pKa:

CX LogP: 9.55

CX LogD: 7.93

Aromatic Rings: 4

Heavy Atoms: 36

QED Weighted: 0.20

Np Likeness Score: -0.21

References

1. Li R, Cheng C, Balasis ME, Liu Y, Garner TP, Daniel KG, Li J, Qin Y, Gavathiotis E, Sebti SM..  (2015)  Design, synthesis and evaluation of marinopyrrole derivatives as selective inhibitors of Mcl-1 binding to pro-apoptotic Bim and dual Mcl-1/Bcl-xL inhibitors.,  90  [PMID:25437618] [10.1016/j.ejmech.2014.11.035]

Source

Source(1):

• Scientific Literature